The Epcoritamab Dilemma: What a Failed Trial Says About Pharmaceutical Ambitions The recent failure of Genmab A/S and AbbVie Inc.
's joint clinical trial for epcoritamab, a promising cancer treatment, has raised serious questions about the future of this high stakes collaboration.
The setback represents a more profound challenge to the pharmaceutical industry's approach to innovation.